170802 ⎘
Detection or diagnosis of diseases; Endocrine or metabolic disorders Pituitary or hypothalamic - pituitary relationships, e.g. vasopressin or ADH related
RATIO BETWEEN LTA4H AND METRNL IN THE ASSESSMENT OF POLYCYSTIC OVARIAN SYNDROME
#2METHOD FOR DIFFERENTIALLY DIAGNOSING ACTH-DEPENDENT CUSHING'S SYNDROME
#3Kisspeptins to Predict and Treat Delayed Puberty
#4REAGENT KIT FOR DETECTING SEX HORMONE AND METHOD FOR DETECTING SEX HORMONE USING SAME
#5METHOD FOR DIFFERENTIALLY DIAGNOSING ACTH-DEPENDENT CUSHING'S SYNDROME
#6Optimizing mifepristone levels for Cushing's patients
#7Method for differentially diagnosing ACTH-dependent Cushing's syndrome
#8Vreceptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
#9Optimizing mifepristone levels for cushing's patients
#10Method for differentially diagnosing ACTH-dependent Cushing's syndrome
#11Optimizing mifepristone levels for Cushing's patients
#12Method for differentially diagnosing ACTH-dependent cushing's syndrome
#13V1B RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF PATIENTS HAVING AN ELEVATED AVP LEVEL AND/OR AN ELEVATED COPEPTIN LEVEL
#14REAGENT KIT FOR DETECTING SEX HORMONE AND METHOD FOR DETECTING SEX HORMONE USING SAME
#15Method for differentially diagnosing ACTH-dependent Cushing's syndrome
#16Optimizing mifepristone levels for cushing's patients
#17Methods for treatment of Cushing'S disease and hypercortisolism using gefitinib
#18METHODS OF DIAGNOSIS AND TREATMENT OF EQUINE LAMINITIS AND CUSHING'S SYNDROME
#19PDE11A mutations in adrenal disease
#20Optimizing mifepristone levels for cushing'S patients
#21Method of assessing growth hormone deficiency in humans by a macimorelin containing composition